The Role of Macrophage Migration Inhibitory Factor in Alzheimer′s Disease: Conventionally Pathogenetic or Unconventionally Protective?
Maria Cristina Petralia(University of Messina), Maria Sofia Basile(University of Catania), Paolo Fagone(University of Catania), Valeria Bruno(Istituto Neurologico Mediterraneo), Katia Mangano(University of Catania), Salvo Danilo Lombardo(University of Catania), Manuela Pennisi(University of Catania), Giuseppe Battaglia(Istituto Neurologico Mediterraneo), Eugenio Cavalli(Centro Neurolesi Bonino Pulejo), Ferdinando Nicoletti(University of Catania), Andrea Saraceno(University of Catania)
Cited by 50
Related Papers
Natural products in drug discovery: advances and opportunities
|Nature Reviews Drug Discovery|2021|5.2k
Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Inhibitors: Rationale and Importance to Inhibiting These Pathways in Human Health
|Oncotarget|2011|579
GSK-3 as potential target for therapeutic intervention in cancer
|Oncotarget|2014|508
The neuropathic pain: An overview of the current treatment and future therapeutic approaches
|International Journal of Immunopathology and Pharmacology|2019|495